ALX-0061 Phase I Bioavailability Study in Healthy Volunteers

Clinical trial NCT02101073 · COMPLETED

Trial details

NCT number: NCT02101073
Sponsor: Ablynx, a Sanofi company
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Rheumatoid Arthritis

Start date: 2014-03-31
Primary completion: 2014-07-31
Enrollment: 70

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.